A multicenter study of apheresis collection of peripheral blood mononuclear (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
April 1, 2015
End Date
December 31, 2020
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
April 1, 2015
End Date
December 31, 2020